Michail Ignatiadis: Join us tomorrow with ⁦Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib
Sep 15, 2023, 18:51

Michail Ignatiadis: Join us tomorrow with ⁦Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib

Quoting Michail Ignatiadis, Jules Bordet Institute, on Twitter:

“Join us tomorrow with Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib, ESMO Virtual Plenary with AACR Expert Commentary: September 2023″

For details click here.
Source: Michail Ignatiadis/Twitter